The following corporate finance-related stories were reported by media:* Forest Laboratories Inc is nearing an agreement to acquire specialty pharmaceutical company Aptalis Holdings Inc from private equity firm TPG Capital LP for about $3 billion, a person familiar with the matter said on Tuesday.
Forest Laboratories, Inc. (Forest) develops, manufactures and sells branded forms of ethical drug products, which requires a physician's prescription. Shares of FRX traded higher by 0.5% or $0.29/share to $58.76. In the past year, the shares have traded as low as $35.22 and as high as $60.29. On average, 1847090 shares of FRX exchange hands on a given day and today's volume is recorded at 2715208.
Source
